全文获取类型
收费全文 | 93334篇 |
免费 | 8432篇 |
国内免费 | 3189篇 |
专业分类
耳鼻咽喉 | 1166篇 |
儿科学 | 1477篇 |
妇产科学 | 842篇 |
基础医学 | 6897篇 |
口腔科学 | 2668篇 |
临床医学 | 11179篇 |
内科学 | 10906篇 |
皮肤病学 | 1721篇 |
神经病学 | 4188篇 |
特种医学 | 2897篇 |
外国民族医学 | 3篇 |
外科学 | 5752篇 |
综合类 | 18529篇 |
一般理论 | 5篇 |
预防医学 | 11976篇 |
眼科学 | 1525篇 |
药学 | 10889篇 |
249篇 | |
中国医学 | 10453篇 |
肿瘤学 | 1633篇 |
出版年
2024年 | 146篇 |
2023年 | 1806篇 |
2022年 | 2921篇 |
2021年 | 4411篇 |
2020年 | 4545篇 |
2019年 | 3046篇 |
2018年 | 2905篇 |
2017年 | 3284篇 |
2016年 | 3553篇 |
2015年 | 3269篇 |
2014年 | 6923篇 |
2013年 | 6970篇 |
2012年 | 6610篇 |
2011年 | 6855篇 |
2010年 | 5389篇 |
2009年 | 4601篇 |
2008年 | 4500篇 |
2007年 | 4766篇 |
2006年 | 3837篇 |
2005年 | 3360篇 |
2004年 | 2781篇 |
2003年 | 2486篇 |
2002年 | 1942篇 |
2001年 | 1851篇 |
2000年 | 1491篇 |
1999年 | 1261篇 |
1998年 | 1031篇 |
1997年 | 862篇 |
1996年 | 739篇 |
1995年 | 832篇 |
1994年 | 742篇 |
1993年 | 589篇 |
1992年 | 557篇 |
1991年 | 503篇 |
1990年 | 437篇 |
1989年 | 415篇 |
1988年 | 368篇 |
1987年 | 349篇 |
1986年 | 299篇 |
1985年 | 342篇 |
1984年 | 241篇 |
1983年 | 173篇 |
1982年 | 211篇 |
1981年 | 121篇 |
1980年 | 130篇 |
1979年 | 93篇 |
1978年 | 93篇 |
1977年 | 67篇 |
1976年 | 69篇 |
1974年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
《Indian journal of medical microbiology》2022,40(4):480-484
BackgroundInvasive Fungal Diseases (IFD), account for high morbidity and mortality in immunocompromised and seriously ill patients worldwide. Early, faster and accurate diagnosis with timely and appropriate patient management is critical for improved patient outcome and antifungal stewardship. Clinical/radiological presentations in IFD are non-specific and microscopy/culture based tests have low sensitivity and long turnaround time. Biomarkers have clinical utility for diagnosing IFD but their interpretation is not straight forward.ObjectivesThis review discusses the salient characteristics, clinical usefulness and limitations of common biomarkers such as Galactomannan (GM), 1–3, β D glucan (βDG), mannan, anti-mannan antibody (Mn/antiMn), Cryptococcal antigen test (CrAg), Nucleic Acid Amplification (NAA) tests and next generation sequencing for diagnosing IFD.ContentsFungal biomarkers are useful adjuncts as screening and diagnostic tools for IFD and are much more suited for ‘ruling out’ rather than ‘ruling in’ disease. GM, NAA tests are promising biomarkers for screening of invasive Aspergillosis in high risk asymptomatic patients who are not on antifungal therapy and for diagnosis of breakthrough infections in symptomatic patients. 1–3, β D glucan has limitations both as a ‘rule in’ and ‘rule out’ test and is useful in only specific clinical settings. Two consecutive positive 1-3-βDG tests or combined positivity with GM increases its specificity. Mn/antiMn, T2Candida nano diagnostic panel are promising candidates for diagnosing invasive candidiasis. Combining two or more biomarkers improves the sensitivity for prompt initiation of antifungal therapy and the negative predictive value for suspension of empirical treatment.Serum CrAg test is a good ‘rule in’ rather than a ‘rule out’ test in immunocompetent patients but has good diagnostic accuracy in immunocompromised patients. Detection of single nucleotide polymorphisms by next generation sequencing is useful for fungal characterization and identification of host determinants responsible for increased susceptibility to fungal infections but is still in experimental stages. 相似文献
4.
5.
《Pediatric Dental Journal》2022,32(2):87-93
ObjectivesThe study aimed to estimate the age of Iraqi children and young adults based on the third molar development to establish Iraqi reference material for orthodontic and forensic purposes, and to investigate the correlation between the estimated and chronological age.MethodsA retrospective analysis of digital orthopantographs of 1515 patients of Iraqi origin, aged from 6 to 25 years was conducted, and the developmental status of the mandibular right third molar for each patient was evaluated using Demirjian et al.’s method. Statistical analysis was carried out using “Mann-Whitney U-test” between genders. The linear regression analysis was performed to obtain “regression formulas” for dental age calculation with chronologic age.ResultsNo statistically significant differences were observed between Iraqi males and females at any age. The median of male and female age of initial calcification of the cuspal tips for mandibular third molars was 9 years, whereas 14 years was the median of age for both genders when the crown was completed. All mandibular right third molars have a complete root formation with apex closure at a median of male and female age 22 years.ConclusionsThe use of Demirjian et al.’s method was appropriate as a reliable age indicator for Iraqi population. A strong correlation was observed between these stages and chronological age. Consequently, reference data have been established for mandibular third molar development in Iraqi population. 相似文献
6.
目的 基于红外热成像技术探讨“扶正温阳法”对阳虚质的影响,探讨阳虚质者红外热图的共性规律,分析判断“扶正温阳法”干预阳虚质人群的疗效。方法 纳入30例阳虚质患者给予益气温阳药物在大椎、肾俞(双侧)、命门等进行穴位贴敷,分别在干预前后运用红外热成像技术测定督脉、腰部、腹部、双手及双足局部温度的变化。结果 干预后阳虚体质患者的督脉、腰部、腹部、双手、双足温度均升高(P<0.05),阳虚体质局部温度得以改善。结论 本研究发现“扶正温阳法”可诱发循经热传导现象,通过调节热能代谢而起到调治阳虚体质的作用,红外热成像技术可用来辅助评价阳虚质的治疗效果,对临床指导制定阳虚质人群的干预方案疗效判定具有指导意义。 相似文献
7.
《Arab Journal Of Gastroenterology》2022,23(1):58-60
A liver abscess is identified as a rare extraintestinal manifestation of Crohn’s disease, with an incidence of approximately 150 in 100,000 patients with this condition. In many of these patients, infectious causes are identified, and the patient’s condition is often noted to improve with antibiotics. An aseptic abscess (AA) is an increasingly recognized entity, especially in patients with inflammatory bowel disease, where repetitive evaluations to identify the infectious cause are futile. The average age of diagnosis for an AA is 29 years. The most common site is the spleen, followed by the lymph nodes and then the liver. In this study, we present a unique case of extensive aseptic liver abscesses extending into the pleural cavity in a young patient with Crohn’s disease. 相似文献
9.
《Journal of vascular and interventional radiology : JVIR》2022,33(9):1034-1044.e29
PurposeTo assess the safety and tolerability of a vandetanib-eluting radiopaque embolic (BTG-002814) for transarterial chemoembolization (TACE) in patients with resectable liver malignancies.Materials and MethodsThe VEROnA clinical trial was a first-in-human, phase 0, single-arm, window-of-opportunity study. Eligible patients were aged ≥18 years and had resectable hepatocellular carcinoma (HCC) (Child-Pugh A) or metastatic colorectal cancer (mCRC). Patients received 1 mL of BTG-002814 transarterially (containing 100 mg of vandetanib) 7–21 days prior to surgery. The primary objectives were to establish the safety and tolerability of BTG-002814 and determine the concentrations of vandetanib and the N-desmethyl vandetanib metabolite in the plasma and resected liver after treatment. Biomarker studies included circulating proangiogenic factors, perfusion computed tomography, and dynamic contrast-enhanced magnetic resonance imaging.ResultsEight patients were enrolled: 2 with HCC and 6 with mCRC. There was 1 grade 3 adverse event (AE) before surgery and 18 after surgery; 6 AEs were deemed to be related to BTG-002814. Surgical resection was not delayed. Vandetanib was present in the plasma of all patients 12 days after treatment, with a mean maximum concentration of 24.3 ng/mL (standard deviation ± 13.94 ng/mL), and in resected liver tissue up to 32 days after treatment (441–404,000 ng/g). The median percentage of tumor necrosis was 92.5% (range, 5%–100%). There were no significant changes in perfusion imaging parameters after TACE.ConclusionsBTG-002814 has an acceptable safety profile in patients before surgery. The presence of vandetanib in the tumor specimens up to 32 days after treatment suggests sustained anticancer activity, while the low vandetanib levels in the plasma suggest minimal release into the systemic circulation. Further evaluation of this TACE combination is warranted in dose-finding and efficacy studies. 相似文献
10.